Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
27 hedge funds and large institutions have $35.8M invested in Apollo Endosurgery, Inc. in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
18% more capital invested
Capital invested by funds: $30.3M → $35.8M (+$5.57M)
17% more funds holding
Funds holding: 23 → 27 (+4)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NSEDCP
NJ State Employees Deferred Compensation Plan
Trenton,
New Jersey
|
+$983K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$593K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$387K |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$146K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$111K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Austin,
Texas
|
-$221K |
| 2 |
DCM
Delpha Capital Management
New York
|
-$57K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$31.8K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$16.7K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$6.28K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$1.11K | -176 | -98% |
|
|
AG
27
Advisor Group
Phoenix,
Arizona
| – | +$31 | +5 | New |
|
APEN Hedge Fund Activity: Q1 2018 in Review
27 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q1 2018, worth a combined $35.8M — up 18% from $30.3M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new APEN positions and 2 closed out — a net gain of 4 holders — while 8 added to existing stakes and 6 trimmed.
The largest buyer was NJ State Employees Deferred Compensation Plan, opening a new position worth an estimated $983K. The largest seller was University of Texas/Texas AM Investment Management Co (UTIMCO), cutting an estimated $221K.
- 27 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q1 2018, up from 23 in Q4 2017.
- Funds reported $35.8M of Apollo Endosurgery, Inc. stock for Q1 2018, up 18% quarter-over-quarter.
- 6 funds opened new Apollo Endosurgery, Inc. positions in Q1 2018 and 2 closed out, a net change of +4 holders.
- The largest Apollo Endosurgery, Inc. buyer in Q1 2018 was NJ State Employees Deferred Compensation Plan, an estimated $983K added.
- The largest Apollo Endosurgery, Inc. seller in Q1 2018 was University of Texas/Texas AM Investment Management Co (UTIMCO), an estimated $221K sold.
Based on aggregated 13F filings for Q1 2018.